NSE · BSE · Real-time
High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.
Gland Pharma Limited has secured USFDA approval and executed the market launch of Sugammadex Injection in the United States. This generic alternative to Bridion targets a substantial perioperative therapy segment that recorded $1.6 billion in annual sales through April 2026.
Real-time NSE & BSE event alerts, AI-summarized filings, and instant order-win signals — free for 15 days, no card required.
